These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21092076)

  • 21. Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.
    Douillard JY; Gervais R; Dabouis G; Le Groumellec A; D'Arlhac M; Spaeth D; Coudert B; Caillaud D; Monnier A; Clary C; Maury B; Mornet M; Rivière A; Clouet P; Couteau C
    Ann Oncol; 2005 Jan; 16(1):81-9. PubMed ID: 15598943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer.
    Oka M; Fukuda M; Nagashima S; Fukuda M; Kinoshita A; Soda H; Doi S; Narasaki F; Suenaga M; Takatani H; Nakamura Y; Kawabata S; Tsurutani J; Kanda T; Kohno S
    Cancer Chemother Pharmacol; 2001 Dec; 48(6):446-50. PubMed ID: 11800024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II study of the docetaxel-carboplatin chemotherapy regimen in advanced non-small-cell lung cancer.
    Tsavaris N; Kosmas C; Skopelitis E; Gennatas K; Zorbala A; Papas P; Gouveris P; Antypas G; Rokana S; Tzelepis G
    Lung; 2005; 183(6):405-16. PubMed ID: 16465600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
    Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
    J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer.
    Belani CP;
    Semin Oncol; 2002 Jun; 29(3 Suppl 12):4-9. PubMed ID: 12170445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase I dose escalation study of weekly docetaxel and carboplatin in elderly patients with nonsmall cell lung cancer.
    Kaira K; Tsuchiya S; Sunaga N; Yanagitani N; Watanabe S; Imai H; Hisada T; Ishizuka T; Saito R; Mori M
    Am J Clin Oncol; 2007 Feb; 30(1):51-6. PubMed ID: 17278895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial.
    Arrieta O; Barrón F; Ramírez-Tirado LA; Zatarain-Barrón ZL; Cardona AF; Díaz-García D; Yamamoto Ramos M; Mota-Vega B; Carmona A; Peralta Álvarez MP; Bautista Y; Aldaco F; Gerson R; Rolfo C; Rosell R
    JAMA Oncol; 2020 Jun; 6(6):856-864. PubMed ID: 32271354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboplatin plus either docetaxel or paclitaxel for Japanese patients with advanced non-small cell lung cancer.
    Kawahara M; Atagi S; Komuta K; Yoshioka H; Kawasaki M; Fujita Y; Yonei T; Ogushi F; Kubota K; Nogami N; Tsuchiya M; Shibata K; Tomizawa Y; Minato K; Fukuoka K; Asami K; Yamanaka T;
    Anticancer Res; 2013 Oct; 33(10):4631-7. PubMed ID: 24123041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer.
    Tan EH; Rolski J; Grodzki T; Schneider CP; Gatzemeier U; Zatloukal P; Aitini E; Carteni G; Riska H; Tsai YH; Abratt R
    Ann Oncol; 2009 Jul; 20(7):1249-56. PubMed ID: 19276396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer.
    Belani CP; Einzig A; Bonomi P; Dobbs T; Capozzoli MJ; Earhart R; Cohen LJ; Luketich JD
    Ann Oncol; 2000 Jun; 11(6):673-8. PubMed ID: 10942054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination chemotherapy with carboplatin and docetaxel for elderly patients with non-small-cell lung cancer].
    Terashima T; Matsuzaki T; Ogawa R; Naitou A; Morishita T; Ishizaka A
    Nihon Kokyuki Gakkai Zasshi; 2008 Jul; 46(7):516-21. PubMed ID: 18700567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
    Rodrigues-Pereira J; Kim JH; Magallanes M; Lee DH; Wang J; Ganju V; Martínez-Barrera L; Barraclough H; van Kooten M; Orlando M
    J Thorac Oncol; 2011 Nov; 6(11):1907-14. PubMed ID: 22005471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial.
    Bouman-Wammes EW; van den Berg HP; de Munck L; Beeker A; Smorenburg CH; Vervenne WL; Coenen JLLM; Verheul HMW; Gerritsen WR; Van den Eertwegh AJM
    Eur J Cancer; 2018 Feb; 90():1-9. PubMed ID: 29268139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
    Giannakakis T; Kakolyris S; Theodoropoulos E; Kouroussis C; Michailakis E; Papadouris S; Tsitoura M; Kalbakis K; Souglakos J; Agelaki S; Vardakis N; Georgoulias V
    Anticancer Res; 2002; 22(6B):3743-8. PubMed ID: 12552987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
    Groen HJ; Sietsma H; Vincent A; Hochstenbag MM; van Putten JW; van den Berg A; Dalesio O; Biesma B; Smit HJ; Termeer A; Hiltermann TJ; van den Borne BE; Schramel FM
    J Clin Oncol; 2011 Nov; 29(32):4320-6. PubMed ID: 21990410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial.
    Schuette W; Nagel S; von Weikersthal LF; Pabst S; Schumann C; Deuss B; Salm T; Roscher K; Dickgreber N
    J Thorac Oncol; 2011 Dec; 6(12):2090-6. PubMed ID: 22052225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial.
    Choy H; DeVore RF; Hande KR; Porter LL; Rosenblatt PA; Slovis B; Laporte K; Shyr Y; Johnson DH
    Lung Cancer; 2001 Dec; 34(3):441-9. PubMed ID: 11714542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial.
    Camps C; Massuti B; Jiménez A; Maestu I; Gómez RG; Isla D; González JL; Almenar D; Blasco A; Rosell R; Carrato A; Viñolas N; Batista N; Girón CG; Galán A; López M; Blanco R; Provencio M; Diz P; Felip E;
    Ann Oncol; 2006 Mar; 17(3):467-72. PubMed ID: 16371411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel and carboplatin as second-line chemotherapy for metastatic non-small cell lung cancer.
    Laack E; Dierlamm T; Knuffmann C; Popp J; Schmied B; Dürk H; Wacker-Backerhaus G; Zeller W; Verpoort K; Fiedler W; Kurt Hossfeld D
    Lung Cancer; 2002 Jun; 36(3):303-7. PubMed ID: 12009242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.